A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01173510
Recruitment Status : Withdrawn (This study was not feasible due to facility budget and contractual issues.)
First Posted : August 2, 2010
Last Update Posted : June 14, 2017
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Community Research Initiative of New England

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Actual Primary Completion Date : October 19, 2012
  Actual Study Completion Date : October 19, 2012